` Comparison: 9202 vs KNRS - Alpha Spread

9202
vs
KNRS

Over the past 12 months, ANA Holdings Inc has outperformed KNRS, delivering a return of +6% compared to the KNRS's 0% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
9202
KNRS
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

Intrinsic Value
4 523.79 JPY
Undervaluation 34%
Intrinsic Value
Price
KNRS Intrinsic Value
Not Available
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
ANA Holdings Inc
TSE:9202
2 988 JPY
Kinarus Therapeutics Holding AG
SIX:KNRS
15 CHF
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
9202, KNRS

9202
KNRS
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
ANA Holdings Inc
Revenue
Kinarus Therapeutics Holding AG
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
9202, KNRS

9202
KNRS
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
ANA Holdings Inc
TSE:9202
Kinarus Therapeutics Holding AG
SIX:KNRS
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

ANA Holdings Inc
18.1%
KNRS
0%

Operating Margin

ANA Holdings Inc
8.5%
KNRS
0%

Net Margin

ANA Holdings Inc
6.5%
KNRS
0%

FCF Margin

ANA Holdings Inc
4.4%
KNRS
0%

ROE

ANA Holdings Inc
12.3%
KNRS
-237.1%

ROA

ANA Holdings Inc
4.3%
KNRS
-219.8%

ROIC

ANA Holdings Inc
7%
KNRS
-247.6%

ROCE

ANA Holdings Inc
8.1%
KNRS
-237%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
9202, KNRS

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
9202, KNRS

Loading
9202
KNRS
Difference
www.alphaspread.com

Performance By Year
9202, KNRS

Loading
9202
KNRS
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 9202 to other stocks
DAL
Delta Air Lines Inc
More expensive
vs ANA Holdings Inc
UAL
United Airlines Holdings Inc
Cheaper
vs ANA Holdings Inc
IAG
International Consolidated Air...
Cheaper
vs ANA Holdings Inc
RYA
Ryanair Holdings PLC
R
More expensive
vs ANA Holdings Inc
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett